from Family Class Polyclinic
Protocols · 20 Sep 2026

Spider Veins: Laser or Sclerotherapy?

Laser and sclerotherapy suit different vessels. Learn how vein size, skin type and the wider venous system shape assessment, treatment choices and realistic expectations.

Spider veins on the legs can be treated with laser or sclerotherapy, depending on vessel size, location and color, skin type and the condition of the venous system. Sclerotherapy is generally preferred for larger reticular veins; laser can suit the smallest superficial vessels. A staged combination may be appropriate. Spider veins are usually not dangerous and often cause concern because of their appearance.

What are spider veins?

Spider veins, or telangiectasias, are small dilated vessels within the skin, measuring up to 1 mm in diameter. They can appear red, purple or bluish, as individual lines, a network or a star-shaped pattern.

Reticular veins are often present nearby. These are larger bluish vessels, roughly 1–3 mm across. Although a patient may see one network of visible veins, distinguishing vessel size and type is important because it helps determine the treatment approach.

Telangiectasias fall within class C1 of the international CEAP classification for chronic venous disease. Their presence alone does not mean that someone has advanced varicose veins or a dangerous circulation problem.

Is a vein ultrasound needed before treatment?

A vein ultrasound is arranged when clinical findings suggest it is needed, rather than for everyone with a few small spider veins. At the appointment, we examine the legs and ask about symptoms, visible varicose veins, swelling, heaviness, pain, previous thrombosis and earlier vein treatment.

Duplex ultrasound is used when there are signs of chronic venous disease or concern that the visible vessels are connected to a larger incompetent vein. It assesses superficial and deep veins and can identify abnormal backward flow, known as venous reflux.

Repeatedly treating small vessels is unlikely to resolve the problem if they are supplied by a larger abnormal vein. In that situation, the underlying venous issue is addressed in the treatment plan before aesthetic correction of the remaining vessels.

When is sclerotherapy usually chosen?

Sclerotherapy is particularly useful for more visible blue or purple reticular veins. A special medicine is placed directly into the vessel through a very fine needle. It damages the inner lining, allowing the vein to close and gradually become less visible.

European Society for Vascular Surgery recommendations identify sclerotherapy as a first-choice treatment for reticular veins, approximately 1–3 mm in diameter. It is also one of the recommended options for telangiectasias up to 1 mm.

In practice, sclerotherapy is particularly useful when a network includes more visible blue or purple reticular veins as well as fine red vessels. Several areas can be treated during one appointment.

The result cannot be judged immediately after the procedure. A treated vessel needs time to close and gradually fade, and it may initially look darker. Several sessions are often needed to achieve the intended cosmetic improvement.

When may laser treatment be appropriate?

Laser can suit very small telangiectasias that are difficult to enter with a needle. A transcutaneous vascular laser uses light absorbed by hemoglobin in the vessel. The light becomes heat and damages the vessel wall while treatment aims to preserve the surrounding skin. Laser may also be considered for someone who is uncomfortable with needle-based procedures, is allergic to a sclerosant, has had insufficient improvement with sclerotherapy, or develops a very fine network called telangiectatic matting.

Different vessels require different laser types and settings. Wavelength, vessel size and depth, skin color, pulse parameters and cooling all matter. The phrase “laser removal” alone says little about how appropriate the treatment will be.

Studies show comparable effectiveness for laser and sclerotherapy in some situations, while sclerotherapy is generally preferred for larger reticular veins. Laser treatment can also be more painful, particularly when treating larger vessels.

Can laser and sclerotherapy be combined?

Laser and sclerotherapy can be combined in stages when vessels of different sizes are present. Larger vessels more often favor sclerotherapy, while laser can be effective for the smallest superficial vessels. The boundary is not fixed at exactly one millimeter.

A single leg may have 2–3 mm reticular veins alongside numerous fine red telangiectasias. A staged combination can be useful: larger feeding reticular veins are treated with sclerotherapy first, followed later by laser for the remaining small vessels.

The choice follows an examination. It should not be based solely on a photograph or on the assumption that laser is better because it appears more modern.

What side effects are possible?

Possible effects after sclerotherapy include hyperpigmentation, telangiectatic matting, small bruises, localized firmness and tenderness in the treated area. These are usually temporary. Hyperpigmentation appears as a brownish line or patch along a treated vessel.

After laser treatment, redness, mild swelling, burning sensations or temporary skin color changes may occur. Inappropriate settings increase the risk of burns and pigmentation changes. Skin type matters, and treatment should not be performed on actively tanned skin.

Sclerotherapy also has rare but more serious complications. Before treatment, the doctor takes a medical history and assesses contraindications and individual risks. It is a medical procedure requiring appropriate assessment.

How many sessions are needed, and are results permanent?

The number of sessions depends on the area involved, vessel size and number, and the response to treatment. A small localized area may need one session, while widespread telangiectasias and reticular veins may require several stages.

Treatment can close the particular vessels being addressed, but neither sclerotherapy nor laser guarantees that new spider veins will not appear nearby in future years. The tendency to develop them may remain. New vessels after successful treatment do not automatically mean that the original procedure was performed incorrectly.

What happens at the consultation?

We first establish whether the concern is telangiectasias, reticular veins or larger varicose tributaries. Both legs are examined, symptoms and risk factors are assessed, and duplex ultrasound is arranged when indicated.

We then discuss the approach suited to those vessels. Reticular veins more often lead us toward sclerotherapy; very fine telangiectasias may be treated with laser. When different vessel sizes are present, treatment may be combined and staged.

We do not promise to remove every visible vessel in one session. The first step is to understand whether there is a larger venous source and then choose a method with a considered balance of effectiveness, safety and realistic cosmetic expectations.

Read about assessment and treatment options on our varicose veins treatment page. If vein changes followed pregnancy, see our article on varicose veins and clot risk after childbirth.

Author: Dr. Nargiz Mamedova, MD, PhD — General Practitioner, Longevity Physician.

Get your own biomarker read.

WhatsAppCallBook now